Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

Seattle Genetics signs $2bn deal for Immunomedics’ cancer drug

Buys rights to breast cancer drug candidate that could be be in line for FDA approval by year end

- PMLiVE

Stada confirms Cinven as one of two takeover bidders

Private equity group offers €3.6bn for the generics and over-the-counter medicines manufacturer

A view from within #LucidLife

As we celebrate our 10 year anniversary, Joanne shares her #LucidLife journey

Lucid Group Communications Limited

- PMLiVE

Global standard for medical writing outlined

International writers' associations aim to strengthen and share best practice

- PMLiVE

McCann Health appoints London and New York heads

Mark Archer and Jamie Avallone both become managing directors

- PMLiVE

Cognite bolsters creative and account teams

David Sartain and Cassandra Johnson join the agency

Deal Watch January 2017

Actelion, Johnson & Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up

Lundbeck partners with IBM Watson on drug research

The deal will also see it set up a new real world evidence platform

Sanofi reception

Praluent can stay on market for now, says US court

Sanofi and Regeneron win appeal to suspended permanent injunction sought by Amgen

- PMLiVE

FDA approves first steroid for Duchenne muscular dystrophy

Marathon Pharma’s Emflaza is first approved to treat all genetic forms of the condition

- PMLiVE

New philosophies driving transformative healthcare

The key trends and philosophies driving this disruptive and innovative era of healthcare forward

- PMLiVE

Minoryx Therapeutics adds to board of directors

Dr Claude Nicaise joins as an independent board member

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links